Dongwei Dou
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 3
- Kruppel-like factors research 2
- RNA Research and Splicing 2
- DNA Repair Mechanisms 1
- Ubiquitin and proteasome pathways 1
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 5
- Co-authors
- Xiaodong Xu (6 shared papers)Mingli Han (6 shared papers)Xin Ge (5 shared papers)Guangcheng Guo (5 shared papers)Yuanting Gu (4 shared papers)Xinxing Wang (4 shared papers)Xiaoyang Ren (3 shared papers)Xueke Qian (3 shared papers)
- Journals
- Cancer Cell International (3 papers)Journal of Cellular Physiology (2 papers)Cell Death and Disease (2 papers)Molecular Oncology (1 paper)Tumor Biology (1 paper)
- Partner nations
- China
In The Last Decade
Dongwei Dou
16 papers receiving 525 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 313
- Molecular Biology 394
- Geriatrics and Gerontology 12
- Oncology 60
- Immunology 30
Countries citing papers authored by Dongwei Dou
This map shows the geographic impact of Dongwei Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongwei Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongwei Dou more than expected).
Fields of papers citing papers by Dongwei Dou
This network shows the impact of papers produced by Dongwei Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongwei Dou. The network helps show where Dongwei Dou may publish in the future.
Co-authors
The 25 scholars most cited alongside Dongwei Dou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 96 | |
| 2 | 2020 | 81 | |
| 3 | 2020 | 56 | |
| 4 | 2020 | 45 | |
| 5 | 2018 | 36 | |
| 6 | 2021 | 30 | |
| 7 | 2018 | 29 | |
| 8 | 2019 | 29 | |
| 9 | 2019 | 24 | |
| 10 | 2021 | 21 | |
| 11 | 2016 | 21 | |
| 12 | 2020 | 18 | |
| 13 | 2020 | 16 | |
| 14 | 2017 | 12 | |
| 15 | lncRNA GHET1 knockdown suppresses breast cancer activity in vitro and in vivo. | 2019 | 11 |
| 16 | 2016 | 4 |
About Dongwei Dou
Dongwei Dou is a scholar working on Molecular Biology, Cancer Research, Immunology, Genetics and Oncology, having authored 16 papers that have together received 529 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers), RNA modifications and cancer (4 papers), Circular RNAs in diseases (3 papers), Kruppel-like factors research (2 papers), RNA Research and Splicing (2 papers), DNA Repair Mechanisms (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Cancer Research (313 citations), Molecular Biology (394 citations), Geriatrics and Gerontology (12 citations), Oncology (60 citations) and Immunology (30 citations). Dongwei Dou has collaborated with scholars based in China. Frequent co-authors include Xiaodong Xu, Mingli Han, Xin Ge, Guangcheng Guo, Yuanting Gu, Xinxing Wang, Xiaoyang Ren, Xueke Qian, Xinhong Pei and Zhe Zhang. Their work appears in journals such as Cancer Cell International, Journal of Cellular Physiology, Cell Death and Disease, Molecular Oncology and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.